Prevention and management of obinutuzumab-associated toxicities: Australian experience
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention and management of obinutuzumab-associated toxicities: Australian experience
Authors
Keywords
-
Journal
International Journal of Nursing Practice
Volume 21, Issue -, Pages 15-27
Publisher
Wiley
Online
2015-12-18
DOI
10.1111/ijn.12412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology
- (2015) Gail L Jones et al. BRITISH JOURNAL OF HAEMATOLOGY
- Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
- (2015) V Goede et al. LEUKEMIA
- Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
- (2015) Valentin Goede et al. Oncology Research and Treatment
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Age on Outcomes After Initial Therapy With Chemotherapy and Different Chemoimmunotherapy Regimens in Patients With Chronic Lymphocytic Leukemia: Results of Sequential Cancer and Leukemia Group B Studies
- (2012) Jennifer A. Woyach et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimal Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia
- (2011) Valentin Goede et al. DRUGS & AGING
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- Chronic lymphocytic leukemia: planning for an aging population
- (2010) John G Gribben Expert Review of Anticancer Therapy
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
- (2009) B. F. Eichhorst et al. BLOOD
- Tumor lysis syndrome: current perspective
- (2008) J. Hochberg et al. HAEMATOLOGICA
- A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly Patients
- (2008) Fabio Salvi et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Chronic lymphocytic leukaemia
- (2008) G Dighiero et al. LANCET
- Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia
- (2008) Paul Thurmes et al. LEUKEMIA & LYMPHOMA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started